On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

St. Josef-Hospital

InstitutionResearch output, impact & collaborations

St. Josef-Hospital is a institution indexed in ScholarIQ from OpenAlex.

What is known about St. Josef-Hospital?

ScholarIQrecord summary

St. Josef-Hospital is a research organisation in Bochum, DE. OpenAlex records 7,126 works and 465,139 citations for it. 1,707 researchers list it as their most recent affiliation.

How many works does St. Josef-Hospital have?

ScholarIQindexed works

St. Josef-Hospital has 7,126 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does St. Josef-Hospital have?

ScholarIQcitation count

St. Josef-Hospital has 465,139 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at St. Josef-Hospital?

ScholarIQresearcher count

St. Josef-Hospital has 1,707 researchers in the ScholarIQ index.

What is the average h-index at St. Josef-Hospital?

ScholarIQavg h-index

St. Josef-Hospital has an average h-index of 81.3 in OpenAlex.

What is the ROR of St. Josef-Hospital?

ScholarIQror

The ROR for St. Josef-Hospital is on the source record.

What is the OpenAlex record for St. Josef-Hospital?

ScholarIQopenalex

The OpenAlex for St. Josef-Hospital is on the source record.

Who are the most-cited researchers behind St. Josef-Hospital?

ScholarIQtop researchers by citations
1
Ralf Gold · Multiple Sclerosis Research Studies
1,261 works48,435 citations
2
Peter Altmeyer · Cutaneous Melanoma Detection and Management
923 works18,534 citations
3
David P. Witte · Lysosomal Storage Disorders Research
314 works17,136 citations

What are the most-cited papers on St. Josef-Hospital?

ScholarIQmost cited works
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos, Amit Bar‐Or, Bruce Cree, Robert J. Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L. Arnold, Sophie Arnould, Tatiana Scherz, Christian Wolf, Erik Wallström, Frank Dahlke, Anat Achiron, Lutz Achtnichts, Kadriye Ağan, Gülşen Akman‐Demir, Alison Allen, Jack P. Antel, Alfredo Rodríguez Antigüedad, Michelle Apperson, Angela Applebee, Guillermo Izquierdo Ayuso, Masayuki Baba, Ovidiu Băjenaru, Rodica Balasa, Belgin Petek Balcı, Michael Barnett, Ann Bass, V. Becker, Mihaela Bejinariu, Florian Then Bergh, Arnfin Bergmann, Evanthia Bernitsas, Achim Berthele, Virender Bhan, Felix Bischof, Randall J. Bjork, Gregg Blevins, Matthias Boehringer, Thomas Boerner, Robert Bonek, James D. Bowen, Allen C. Bowling, Alexey Boyко, Cavit Boz, Vera Bracknies, Stefan Braune, Vincenzo Brescia Morra, Bruno Brochet, Waldemar Brola, Paul Brownstone, M Brozman, Donald Brunet, Ioan Buraga, Margaret Burnett, Mathias Buttmann, Helmut Butzkueven, Jonathan Cahill, Jonathan Calkwood, William Camu, Mark Cascione, G. Castelnovo, Diego Centonze, João Cerqueira, Andrew Chan, Andrea Cimprichová, Stanley Cohan, Giancarlo Comi, Jill Ker Conway, Joanna A. Cooper, John R. Corboy, Jorge Correale, Brian Costell, David A. Cottrell, Patricia K. Coyle, Matthew Craner, Liying Cui, Luı́s Cunha, Anna Członkowska, Ana Silva, Joao de, de Sèze, Marc Debouverie, Jan Debruyne, D. Decoo, G. Defer, Tobias Derfuß, Norma Deri, Bhupesh Dihenia, Péter Diószeghy, Vladimír Donáth, Bénédicte Dubois, Martin Duddy, Pierre Duquette, Gilles Edan, Hüsnü Efendi, Stanton B. Elias, Peter Emrich, Bonaventura Casanova Estruch
The Lancet. 2018932 Citations
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Xavier Montalbán, Ralf Gold, Alan J. Thompson, Susana Otero-Romero, Maria Pia Amato, Dhia Chandraratna, M. Clanet, Gıancarlo Comı, Tobias Derfuß, Franz Fazekas, Hans Hartung, Eva Havrdová, Bernhard Hemmer, Ludwig Kappos, Roland Liblau, Catherine Lubetzki, Elena Marcus, David H. Miller, Tomas Olsson, Steve Pilling, Krzysztof Selmaj, Aksel Sıva, Per Soelberg Sørensen, Maria Pia Sormani, Christoph Thalheim, Heinz Wiendl, Frauke Zipp
Multiple Sclerosis Journal. 2018710 CitationsOPEN ACCESS
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Tania Kümpfel, Katrin Giglhuber, Orhan Aktaş, Ilya Ayzenberg, Judith Bellmann–Strobl, Vivien Häußler, Joachim Havla, Kerstin Hellwig, Martin W. Hümmert, Sven Jarius, Ingo Kleiter, Luisa Klotz, Markus Krumbholz, Friedemann Paul, Marius Ringelstein, Klemens Ruprecht, Makbule Şenel, Jan‐Patrick Stellmann, Florian Then Bergh, Corinna Trebst, Hayrettin Tumani, Clemens Warnke, Brigitte Wildemann, Achim Berthele, The Neuromyelitis Optica Study Group (NEMOS), Philipp Albrecht, Klemens Angstwurm, Susanna Asseyer, Ana Beatriz Ayroza Galvão Ribeiro Gomes, Antonios Bayas, Stefanie Behnke, Stefan Bittner, Franziska Buetow, Mathias Buttmann, Ankelien Duchow, Daniel Engels, Thorleif Etgen, Katinka Fischer, Benedikt Frank, Anna Gahlen, Achim Gass, Johannes Gehring, Christian Geis, Ralf Gold, Yasemin Göreci, Jonas Graf, Sergiu Groppa, Matthias Grothe, Julia Gutbrod, Kersten Guthke, Axel Haarmann, Maria Hastermann, Bernhard Hemmer, Mariella Herfurth, Marina Herwerth, Frank Hoffmann, Olaf Hoffmann, Martin W. Hümmert, Leila Husseini, Jutta Junghans, Matthias Kaste, Peter Kern, Karsten Kern, Pawel Kermer, Christoph Kleinschnitz, Wolfgang Köhler, Kimberly Körbel, Markus C. Kowarik, Markus Kraemer, Julian Reza Kretschmer, Natalia Kurka, Theodoros Ladopoulus, Ann-Sophie Lauenstein, Sarah Laurent, De-Hyung Lee, Dominik Lehrieder, Frank Leypoldt, Martin Liebetrau, Ralf A. Linker, Gero Lindenblatt, Lisa Lohmann, Felix Lüssi, Peter Luedemann, Michelle Maiworm, Martin Marziniak, Christoph Mayer, Stefanie Meister, Mathias Mering, Imke Metz, Sven G. Meuth, Jasmin Naumann, Oliver Neuhaus, Tradite Neziraj, Moritz Niederschweiberer, Sabine Niehaus, Carolin Otto, Florence Pache, Thivya Pakeerathan, Sarah Passoke, Marc Pawlitzki
Journal of Neurology. 2023243 CitationsOPEN ACCESS
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
Lara Kular, Yun Liu, Sabrina Ruhrmann, Galina Yurevna Zheleznyakova, Francesco Marabita, David Gómez-Cabrero, Tojo James, Ewoud Ewing, Magdalena Lindén, Bartosz Górnikiewicz, Shahin Aeinehband, Pernilla Stridh, Jenny Link, Till F. M. Andlauer, Christiane Gasperi, Heinz Wiendl, Frauke Zipp, Ralf Gold, Björn Tackenberg, Frank Weber, Bernhard Hemmer, Konstantin Strauch, Stefanie Heilmann‐Heimbach, Rajesh Rawal, Ulf Schminke, Carsten Oliver Schmidt, Tim Kacprowski, André Franke, Matthias Laudes, Alexander Dilthey, Elisabeth Gulowsen Celius, Helle Bach Søndergaard, Jesper Tegnér, Hanne F. Harbo, Annette Oturai, Sigurgeir Ólafsson, Hannes P. Eggertsson, Bjarni V. Halldórsson, Haukur Hjaltason, Elías Ólafsson, Ingileif Jónsdóttir, Kāri Stefánsson, Tomas Olsson, Fredrik Piehl, Tomas J. Ekström, Ingrid Kockum, Andrew P. Feinberg, Maja Jagodic
Nature Communications. 2018215 CitationsOPEN ACCESS
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuß, Ralf A. Linker, Mathias Mäurer, Orhan Aktaş, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czapliński, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans‐Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding‐Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp, for the ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG)
Therapeutic Advances in Neurological Disorders. 2021194 CitationsOPEN ACCESS

How much of the research on St. Josef-Hospital is open access?

ScholarIQopen access share
80%OPEN ACCESS
Gold
40%
Green
0%
Hybrid
20%
Bronze
20%
Closed
20%

Related on ScholarIQ

470M+ articles · 14-day free trial